ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,068Medicare Part D Prescriptions Filled, Including Refills

Rank: 195 out of 1121

$741K Total Retail Price of All Prescriptions

Rank: 183 out of 1121

510 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 510 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 12,503 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 538 534 1 1
LEVOTHYROXINE SODIUM 404 387 2 2
LISINOPRIL 387 387 3 4
ATORVASTATIN CALCIUM 328 319 4 15
OMEPRAZOLE 319 309 5 6
AMLODIPINE BESYLATE 253 242 6 5
TRAZODONE HCL 249 244 7 40
FUROSEMIDE 234 226 8 7
MIRTAZAPINE 232 230 9 56
METOPROLOL TARTRATE 220 204 10 9
HYDROCODONE-ACETAMINOPHEN 218 216 S3 11 3
CITALOPRAM HBR 203 193 12 18
ZOLPIDEM TARTRATE 202 194 13 19
DONEPEZIL HCL 193 193 14 35
WARFARIN SODIUM 182 181 15 11
PANTOPRAZOLE SODIUM 175 148 16 29
HYDROCHLOROTHIAZIDE 163 150 17 10
SPIRONOLACTONE 157 140 18 54
GABAPENTIN 152 151 19 13
LOSARTAN POTASSIUM 147 147 20 17
CRESTOR 144 140 21 28
POLYETHYLENE GLYCOL 3350 139 126 22 70
METFORMIN HCL 127 127 23 8
LOVASTATIN 125 125 24 26
FAMOTIDINE 122 115 25 63
NAMENDA 120 120 26 53
METHYLPREDNISOLONE 118 111 27 97
TAMSULOSIN HCL 117 117 28 32
ESCITALOPRAM OXALATE 113 112 29 94
CARVEDILOL 106 106 30 20
CYMBALTA 106 93 30 50
GLIMEPIRIDE 105 97 32 34
DIOVAN 105 105 32 45
FLUOXETINE HCL 104 78 34 60
QUETIAPINE FUMARATE 101 81 35 75
AZITHROMYCIN 101 97 35 44
FLUTICASONE PROPIONATE 98 89 37 36
ATENOLOL 98 84 37 16
EVISTA 96 95 39 143
RISPERIDONE 91 79 40 82
METOPROLOL SUCCINATE 89 89 41 23
METFORMIN HCL ER 86 77 42 47
LOSARTAN-HYDROCHLOROTHIAZIDE 81 79 43 46
PREDNISONE 79 78 44 43
FENTANYL 75 75 S2 45 100
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 73 46 31
SERTRALINE HCL 72 60 47 21
CLONIDINE HCL 71 71 48 39
PAROXETINE HCL 64 64 49 58
MELOXICAM 63 62 50 22
LEXAPRO 62 62 51 218
AMLODIPINE BESYLATE-BENAZEPRIL 62 62 51 65
PREMARIN 61 61 R 53 96
POTASSIUM CHLORIDE 59 59 54 12
PRAVASTATIN SODIUM 57 53 55 14
SYNTHROID 57 52 55 55
CIPROFLOXACIN HCL 57 53 55 57
CEFDINIR 56 51 58 183
LIPITOR 56 56 58 106
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 49 60 108
ALLOPURINOL 53 53 61 30
EXELON 52 52 62 119
ZETIA 52 52 62 80
TRICOR 51 51 64 126
DIOVAN HCT 50 50 65 90
DIVALPROEX SODIUM 50 46 65 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.